ES2072869T3 - Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo. - Google Patents

Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.

Info

Publication number
ES2072869T3
ES2072869T3 ES89102704T ES89102704T ES2072869T3 ES 2072869 T3 ES2072869 T3 ES 2072869T3 ES 89102704 T ES89102704 T ES 89102704T ES 89102704 T ES89102704 T ES 89102704T ES 2072869 T3 ES2072869 T3 ES 2072869T3
Authority
ES
Spain
Prior art keywords
alcoholism
treatment
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102704T
Other languages
English (en)
Inventor
Klaus Prof Dr Opitz
Jorg Dr Traber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Application granted granted Critical
Publication of ES2072869T3 publication Critical patent/ES2072869T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LOS MEDICAMENTOS QUE CONTIENEN DERIVADOS DE 1,4 - DIHIDROPIRIDINA PUEDEN APLICARSE EN EL TRATAMIENTO DE ALCOHOLISMO.
ES89102704T 1988-02-27 1989-02-17 Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo. Expired - Lifetime ES2072869T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3806277A DE3806277A1 (de) 1988-02-27 1988-02-27 Verwendung von 1,4-dihydropyridin-derivaten

Publications (1)

Publication Number Publication Date
ES2072869T3 true ES2072869T3 (es) 1995-08-01

Family

ID=6348349

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102704T Expired - Lifetime ES2072869T3 (es) 1988-02-27 1989-02-17 Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.

Country Status (10)

Country Link
US (1) US4918076A (es)
EP (1) EP0330924B1 (es)
JP (1) JP2965576B2 (es)
AT (1) ATE122886T1 (es)
DE (2) DE3806277A1 (es)
DK (1) DK89289A (es)
ES (1) ES2072869T3 (es)
FI (1) FI890864A (es)
HU (1) HU202107B (es)
IL (1) IL89401A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
CA2016465A1 (en) * 1989-06-02 1990-12-02 Zola Phillip Horovitz Method for preventing or treating anxiety employing a calcium channel blocker
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
SE9203857D0 (sv) * 1992-12-22 1992-12-22 Astra Ab Use of an enantiomeric dihydropyridine
ES2193148T3 (es) 1993-12-10 2003-11-01 Bayer Ag 1,4-dihidropiridinas sustituidas con fenilo con actividad cerebral.
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422139D0 (en) * 1984-09-01 1984-10-03 Fisons Plc Biologically active nitrogen heterocyclics
ATE84713T1 (de) * 1985-05-13 1993-02-15 Miles Inc Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.
DE3741414A1 (de) * 1987-12-07 1989-06-15 Luitpold Werk Chem Pharm Verwendung von calciumantagonisten bei der behandlung von entzuendungen und oedemen

Also Published As

Publication number Publication date
FI890864A0 (fi) 1989-02-23
EP0330924A2 (de) 1989-09-06
DE3806277A1 (de) 1989-09-07
FI890864A (fi) 1989-08-28
JPH01268636A (ja) 1989-10-26
HU202107B (en) 1991-02-28
DE58909244D1 (de) 1995-06-29
HUT50633A (en) 1990-03-28
US4918076A (en) 1990-04-17
EP0330924A3 (de) 1991-11-13
ATE122886T1 (de) 1995-06-15
DK89289D0 (da) 1989-02-24
DK89289A (da) 1989-08-28
EP0330924B1 (de) 1995-05-24
IL89401A (en) 1994-05-30
IL89401A0 (en) 1989-09-10
JP2965576B2 (ja) 1999-10-18

Similar Documents

Publication Publication Date Title
ES2059775T3 (es) Composicion que contiene morfina.
DK625289A (da) Bicyclo(3.3.1)nonan-derivater
DK330789D0 (da) Substituerede 1,7-annellerede 1 h-indazoler
DE68910799D1 (de) Faserbehandlungszusammensetzung.
MX17877A (es) Composiciones antimalaria y metodos de tratamiento que utilizan quinidina, artemisinina y sus derivados.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
IT8522578A0 (it) Derivati del flavone.
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IT8920929A0 (it) Nuovi derivati del r( ) 3 chinuclidinolo.
ES2062145T3 (es) 1,8-naftiridinas substituidas.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
DE68913088T2 (de) Faserbehandlungszusammensetzung.
IT8621397A0 (it) Derivati del pirrolidin-2-one adattivita' nootropa.
MX9203632A (es) Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen.
DE68907609D1 (de) Arzneimittelzusammensetzung.
IT8822539A0 (it) Nuovi derivati 4 demetossi antraciclinici.
DE68901799D1 (de) Cyclische amp-derivate enthaltende salben.
IT1216999B (it) Derivati di prolina.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
DE68906449D1 (de) Herstellung von 2,6-dioxopiperidinderivate.
DK37787D0 (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
ATE80873T1 (de) Tetrahydropyridin-derivate.
IT1216830B (it) Derivati 1,4-diidropiridinici quali agenti emoreologici
IT8821746A0 (it) Derivati della 1,5 difenil-1h- 1,2,4-triazol-3-carbossamide e composizione diserbante contenente gli stessi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 330924

Country of ref document: ES